Dr. Volker Diehl from the University of Cologne Discusses Brentuximab Vedotin
Volker Diehl, MD
Advertisement
Articles by Volker Diehl, MD
Dr. Volker Diehl from the University of Cologne, Germany, Compares US and EU Hodgkin Lymphoma Staging
Dr. Volker Diehl from the University of Cologne, Germany on the Unique Nature of Hodgkin's Lymphoma
Advertisement
Latest Updated Articles
Dr. Diehl on the Unique Nature of Hodgkin's LymphomaNovember 8th 2011
Dr. Diehl Compares US and EU Hodgkin Lymphoma StagingNovember 14th 2011
Dr. Diehl Discusses Brentuximab VedotinNovember 21st 2011
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
3
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
4
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
5